FDA clearance for Binax Bacterial Meningitis
Binax have announced an additional cleared application for the patented Streptococcus pneumoniae Antigen Test.
The test can be used on CSF for the detection of bacterial meningitis caused by S. pneumoniae
Binax recently announced an exclusive distribution partnership with Remel Inc to provide rapid tests to hospital and clinical reference laboratories in the USA.
NOTE: This item is from our 'historic' database and may contain information which is not up to date.
Source : Binax, Inc. [USA]
Now part of Alere, Inc View Company Information
Posted on December 15, 2001
Get our eNewsletter
Over 6,000 microbiology professionals get our weekly eNewsletter - subscribe now and find out why!
LATEST MICROBIOLOGY NEWS
- Why Cross-Contamination is the Most Significant Risk in the Production of Meat and How to Avoid it
- CytoQuant® - Immediate Verification of Cleaning & Disinfection Procedures
- The Race Isn’t Over Yet - Efficient Discovery, Development and QC of Antibodies
- Microbiome Research with Comprehensive Sequencing Solutions
- INTEGRA Offers Answers to Your Cell Culture Throughput Needs
- The Bactiscan™ Gains International Recognition
- The New AirPrep™ Cub Sampler by InnovaPrep
- Bulk Gold Nanomaterials for Point of Care Diagnostics
- BD Kiestra™ IdentifA - Smart Connected Robotics Automates Microbial Identification
- Neogen to Combine with 3M Food Safety Creating a Global Industry Leader
MICROBIOLOGY EVENTS
- MES for the Future - Free Webinar
- Controlling Parasites Associated with Raw Feeding and the Role of Testing
- Pharmaceutical Environmental Monitoring
- CMI International Microbiome Meeting (CIMM)
- BioMedica
- 2022 QC Micro Summit
- Microbiology Society Annual Conference 2022
- SMi's 5th Annual Pharmaceutical Microbiology East Coast
- WMFMeetsItaly World Mycotoxin Forum
- IAFP 2022